Homology Medicines (LTS:0T6G) Common Stock : $0.01 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Homology Medicines Common Stock?

Homology Medicines's quarterly common stock stayed the same from Jun. 2023 ($0.01 Mil) to Sep. 2023 ($0.01 Mil) and stayed the same from Sep. 2023 ($0.01 Mil) to Dec. 2023 ($0.01 Mil).

Homology Medicines's annual common stock stayed the same from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.01 Mil) and stayed the same from Dec. 2022 ($0.01 Mil) to Dec. 2023 ($0.01 Mil).

Homology Medicines Common Stock Historical Data

The historical data trend for Homology Medicines's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Homology Medicines Common Stock Chart

Homology Medicines Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.01

Homology Medicines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Homology Medicines Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Homology Medicines (LTS:0T6G) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Homology Medicines Inc (LTS:0T6G) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

FIXX:USA 35H:Germany

Address

One Patriots Park, Bedford, MA, USA, 01730

Website

https://www.homologymedicines.com

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Homology Medicines (LTS:0T6G) Headlines

No Headlines